Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07472244

Does the Development of the Repeated Bout Effect Depend on Oxidative Stress and Inflammation?

Eccentric exercise, particularly when novel and strenuous, can cause soreness and inflammation, impairing subsequent exercise performance. These performance decrements are attributable to oxidative stress and inflammation. Interestingly, a single bout of eccentric exercise can confer protective effects, ameliorating the negative consequences in subsequent bouts. This is termed the repeated bout effect (RBE), which would be of interest to athletes considering the detrimental effects of strenuous eccentric exercise. Athletes regularly consume supplements in hope of attenuating the performance decrements after strenuous eccentric exercise

. However, considering the dose-response relationship between the initial performance decrement and the magnitude of the RBE , supplements may diminish the obtainment of the RBE. This notion remains untested, and so the proposed project is a double-blind, placebo-controlled, parallel group study aiming to assess the effects of acute vitamin C and ibuprofen supplementation on the development of the RBE. These two supplements were chosen as they are most frequently and successfully used in the literature to target oxidative stress (vitamin C) and inflammation (ibuprofen). Additionally, these doses (and the timing of supplements) were chosen to mimic protocols reporting beneficial effects

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

18 year–45 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 - 45 years of age
  • BMI 18.5 - 29.9 kg/m2
  • Able to perform 20-minutes of bench stepping exercise
  • Capable and willing to provide consent (oral and written)

Exclusion criteria

  • Familiarised with bench stepping exercise procedures
  • Not cleared for exercise by health questionnaires or physical activity readiness questionnaire
  • Participants exhibiting any alteration in clinical inflammation parameters due to other cause
  • Participants currently being prescribed any anti-inflammatory medications

Treatment and study plan

Control

Dietary Supplement

Identical maltodextrin tablet. Appearance and weight matched

Intervention

Dietary Supplement

1,000 mg Vitamin C and 400 mg non-steroidal anti-inflammatory drug every 8-h for 48-h

Primary outcomes

  1. Muscle Function

    Time frame: Baseline and post exercise (2 hours, 1 day, 7 day)

    Jump height calculated through flight time

Secondary outcomes

  1. Muscle Function

    Time frame: Baseline and post exercise (2 hours, 1 day, 7 day)

    Peak power quantified using a Keiser Leg Press

  2. Muscle Function

    Time frame: Baseline and post exercise (2 hours, 1 day, 7 day)

    Peak force quantified using a Keiser Leg Press

  3. Muscle Function

    Time frame: Baseline and post exercise (2 hours, 1 day, 7 day)

    Peak velocity quantified using a Keiser Leg Press

  4. Creatine Kinase

    Time frame: Baseline and immediately, 1-h (hour)-, 2-h-, 24-h-,and 48-hours-post-exercise

    Plasma Creatine Kinase

Sponsors and collaborators

Lead sponsor

University of Bath

Other

Registry information

Acronym: ANTI-RBE

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Mar 16, 2026
Registry last updated
Mar 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.